TickerFacts.

NRX Pharmaceuticals, Inc. (NRXP): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$10.64M
Year ended 2024-12-31
2020-12-31: -$2.27M2021-12-31: -$37.71M2022-12-31: -$39.77M2023-12-31: -$21.66M2024-12-31: -$10.64M-$10.64M
2020-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$10.64Mn/m2026-03-23, From 2024-01-01
2023-12-31-$21.66Mn/m2025-03-14, From 2023-01-01
2022-12-31-$39.77Mn/m2024-03-29, From 2022-01-01
2021-12-31-$37.71Mn/m2023-03-31, From 2021-01-01
2020-12-31-$2.27Mn/a2022-03-31, From 2020-01-01